Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Denosumab for bone bonding in hip prosthesis
NCT01926158Phase 4Completed
- Sponsor
- Turku University Hospital
- Start
- Dec 2013
- Primary completion
- Feb 2017
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 4 trial of denosumab in hip osteoarthritis, sponsored by Turku University Hospital. Started Dec 2013; status: completed.
02
Drugs
denosumab
03
Conditions
hip osteoarthritis
Beyond the preview
Go deeper on NCT01926158.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01926158.